» Authors » Antonis S Manolis

Antonis S Manolis

Explore the profile of Antonis S Manolis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 174
Citations 4956
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Manolis A, Manolis T, Vouliotis A, Manolis A
Trends Cardiovasc Med . 2025 Jan; PMID: 39848507
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed nonalcoholic fatty-liver disease, is an important and rising health issue with a link with atherosclerotic cardiovascular (CV) disease (CVD), affecting ∼25-30 %...
2.
Manolis T, Manolis A, Manolis A
Curr Vasc Pharmacol . 2025 Jan; PMID: 39754763
Introduction/objective: Emotional, mental, or psychological distress, defined as increased symptoms of depression, anxiety, and/or stress, is common in patients with chronic diseases, such as cardiovascular (CV) disease (CVD). Methods: Literature...
3.
Manolis A, Manolis T, Manolis A
Curr Vasc Pharmacol . 2025 Jan; PMID: 39754762
Introduction/objective: Atrial fibrillation (AF) could present with slow ventricular-response; bradycardia could facilitate the emergence of AF. The conviction that one "does not succumb" from bradycardia as an escape rhythm will...
4.
Manolis T, Manolis A, Manolis A
Curr Vasc Pharmacol . 2024 Oct; PMID: 39411939
Introduction/objective: The influence of cognitive behavioral therapy (CBT) and its modalities on various neuropsychiatric conditions is herein explored together with their impact on specific cardiovascular (CV) diseases (CVD). Methods: A...
5.
Manolis A, Manolis T, Manolis A
Heart Rhythm . 2024 Oct; PMID: 39395570
Circadian rhythms follow 24-hour biological cycle patterns controlled by internal biological or circadian clocks that optimize organismal homeostasis according to predictable environmental changes. These clocks are found in virtually all...
6.
Manolis A, Manolis T, Manolis A
Curr Vasc Pharmacol . 2024 Sep; PMID: 39313895
Atrial fibrillation (AF) is the commonest cardiac arrhythmia, constituting a major cause of morbidity and mortality, with an age-dependent incidence and prevalence ranging from 1-2% in the general population to...
7.
Manolis A, Manolis T, Manolis A
Eur J Intern Med . 2024 Jul; 130:176-178. PMID: 39033055
No abstract available.
8.
Manolis A, Manolis T, Manolis A
Curr Med Chem . 2024 Jun; 32(6):1040-1064. PMID: 38840391
The aim of this review was to examine the literature regarding younger individuals without classical risk factors for atherosclerosis who develop coronary artery disease (CAD) prematurely at an early age....
9.
Manolis A, Manolis T, Mikhailidis D, Manolis A
Biomark Insights . 2024 Jun; 19:11772719241257410. PMID: 38827240
Lipid-lowering therapies, particularly non-statin regimens, are underutilized as ~2/3 of patients with atherosclerotic cardiovascular (CV) disease (CVD) are not optimally managed, and do not attain target low-density lipoprotein cholesterol (LDL-C)...
10.
Manolis A, Manolis T, Manolis A
Expert Rev Cardiovasc Ther . 2024 May; 22(6):243-263. PMID: 38757743
Introduction: Chronic coronary syndrome (CCS) remains the leading cause of death worldwide with high admission/re-admission rates. Medical databases were searched on CCS & its management. Areas Covered: This review discusses...